psychedelics

MindMed sets milestone in finding psychedelic cure for opioid addiction

The company has come up with a derivative of ibogaine, a psychoactive substance from an African shrub.

0

PharmaTher advances in work to develop microneedle patch for psychedelics

Toronto company seeks to come up with alternative way to administer psychedelic substances.

0

Optimi Health completes development of mushroom facility in B.C.

The Vancouver functional and psychedelic fungi company has applied for a Health Canada dealer’s licence.

0

Vancouver cannabis processor Nextleaf applies for psychedelics licence

The Vancouver-based company wants to engage in range of activities related to psilocybin and psilocin.

0

Marvel Biosciences starts work on psychedelics-inspired compounds

The Calgary-based life sciences company hopes to develop treatments for mental health conditions.

0

Love Pharma to develop psilocybin-infused oral strips

Sublingual or the administration of medicines under the tongue allows for quick absorption.

0

Cybin Inc. seeks patent for inhalation delivery of psychedelic medications

The Toronto company is developing a psychedelic drug for anxiety disorders.

0

Academic reflects on bioethical issues in medicalization of psychedelics

Australian researcher cites need to explore ethical issues regarding the use of psychedelics as medicine.

0

Nova Mentis looks at potential psilocybin treatment for obesity and diabetes

People with obesity and diabetes may have an alternative way to get better with the psychedelic substance psilocybin.

0